On Monday, Korro Bio Inc (NASDAQ: KRRO) opened lower -5.43% from the last session, before settling in for the closing price of $11.42. Price fluctuations for KRRO have ranged from $11.00 to $98.00 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has dropped its sales by -39.89% annually for the last half of the decade. Company’s average yearly earnings per share was noted -0.98% at the time writing. With a float of $5.49 million, this company’s outstanding shares have now reached $9.39 million.
In an organization with 104 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 62.17%, operating margin of -1980.44%, and the pretax margin is -1810.56%.
Korro Bio Inc (KRRO) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Korro Bio Inc is 41.54%, while institutional ownership is 72.03%. The most recent insider transaction that took place on Nov 11 ’24, was worth 56,000. In this transaction Chief Financial Officer of this company sold 800 shares at a rate of $70.00, taking the stock ownership to the 0 shares. Before that another transaction happened on Nov 11 ’24, when Company’s Officer proposed sale 800 for $70.00, making the entire transaction worth $56,000.
Korro Bio Inc (KRRO) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -2.36 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -0.98% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -0.45% during the next five years compared to 21.83% growth over the previous five years of trading.
Korro Bio Inc (NASDAQ: KRRO) Trading Performance Indicators
Check out the current performance indicators for Korro Bio Inc (KRRO). In the past quarter, the stock posted a quick ratio of 9.41. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 21.04.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -9.44, a number that is poised to hit -2.57 in the next quarter and is forecasted to reach -8.89 in one year’s time.
Technical Analysis of Korro Bio Inc (KRRO)
Let’s dig in a bit further. During the last 5-days, its volume was 0.23 million. That was better than the volume of 96778.0 it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 6.48%. Additionally, its Average True Range was 1.76.
During the past 100 days, Korro Bio Inc’s (KRRO) raw stochastic average was set at 1.56%, which indicates a significant decrease from 7.92% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 72.01% in the past 14 days, which was lower than the 101.64% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $15.68, while its 200-day Moving Average is $35.38. However, in the short run, Korro Bio Inc’s stock first resistance to watch stands at $11.87. Second resistance stands at $12.94. The third major resistance level sits at $13.73. If the price goes on to break the first support level at $10.01, it is likely to go to the next support level at $9.22. The third support level lies at $8.15 if the price breaches the second support level.
Korro Bio Inc (NASDAQ: KRRO) Key Stats
There are currently 9,391K shares outstanding in the company with a market cap of 101.42 million. Presently, the company’s annual sales total 2,270 K according to its annual income of -83,580 K. Last quarter, the company’s sales amounted to 2,550 K and its income totaled -23,390 K.
